• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ICU MEDICAL COSTA RICA LTD. PLUM 360¿ INFUSER; PUMP, INFUSION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ICU MEDICAL COSTA RICA LTD. PLUM 360¿ INFUSER; PUMP, INFUSION Back to Search Results
Catalog Number 300100413
Device Problem Inaccurate Flow Rate (1249)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/16/2023
Event Type  malfunction  
Event Description
The event involved a plum 360 infusion pump.It was reported that at 23:01 a nurse sent an order for diltiazem to the pump.Shortly after, the bag was found empty with the patient receiving the entire bag in mere minutes.The screen of the pump showed the prior programming from hours earlier.The reporter stated that he could not replicate how the pump could receive programming, reject it, and still retain the prior programming from before it was last powered off.At 23:01 the prior programming had drug library settings that would allow the new programming to interrupt it.There was patient involvement, there was patient harm or adverse event reported and there was delay in therapy.
 
Manufacturer Narrative
The device is not available for investigation.However, device logs will be evaluated, but the evaluation is not yet complete.
 
Manufacturer Narrative
Since the device was not returned to the service hub for analysis and evaluation, no visual inspection and functional testing were performed to determine if the device had a role in the adverse event.Engineering evaluates the pump performed correctly per design.The auto program was rejected automatically by the pump due to the auto programmed drug being defined as non-interruptible while there was a programmed piggyback infusion defined on line b.This rejection was correct as per the plum design requirements.The clinician pressed [start] following the ap auto-rejection which had the effect of restarting the existing (iv fluid bolus @ 500 ml/hr) line a program, instead of the rejected (diltiazem at 50 ml/hr) auto program.This was correct pump behavior as the ap had been rejected.The pump delivered accurately as programmed within design tolerance.Engineering evaluates the probable cause of the bag running dry was user error: specifically, the clinician having loaded a 100 ml bag of diltiazem (less priming volume) and then restarting the program for iv fluid bolus.The customer is aware of the cause and has confirmed satisfaction with the explanation and resolution.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLUM 360¿ INFUSER
Type of Device
PUMP, INFUSION
Manufacturer (Section D)
ICU MEDICAL COSTA RICA LTD.
zona franca global
la aurora heredia
CS 
Manufacturer Contact
michael visocnik
600 n. field dr.
lake forest, IL 60045
2247062300
MDR Report Key16666914
MDR Text Key312600665
Report Number9615050-2023-00100
Device Sequence Number1
Product Code FRN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K161469
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number300100413
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/17/2023
Initial Date FDA Received04/03/2023
Supplement Dates Manufacturer Received05/08/2023
Supplement Dates FDA Received05/09/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
DILTIAZEM, UNK MFR
-
-